Twenty-four-month α-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters

: Koskenvuo J., Hartiala J., Nuutila P., Kalliokoski R., Viikari J., Engblom E., Penttinen M., Knuuti J., Mononen I., Kantola I.

: 2008

 Journal of Inherited Metabolic Disease

: Journal of Inherited Metabolic Disease

: 31

: 3

: 432

: 441

: 10

: 01418955 15732665

DOI: https://doi.org/10.1007/s10545-008-0848-3

: https://api.elsevier.com/content/abstract/scopus_id/45849123200